The underlying hypothesis is that disrupting the enzymatic activity of HSP90 would reverberate on the chaperone protein folding machinery, simultaneously affecting multiple oncoproteins that are essential to the proliferation and maintenance of cancer cells. The gene discussed is HSP90AA1; the disease is cancer.